97 related articles for article (PubMed ID: 4731230)
1. Resistance of cyclocytidine to cytidine deaminase.
Hoshi A; Iigo M; Saneyoshi M; Kuretani K
Chem Pharm Bull (Tokyo); 1973 Jul; 21(7):1535-8. PubMed ID: 4731230
[No Abstract] [Full Text] [Related]
2. Deamination of 5-azacytidine by a human leukemia cell cytidine deaminase.
Chabner BA; Drake JC; Johns DG
Biochem Pharmacol; 1973 Nov; 22(21):2763-5. PubMed ID: 4128550
[No Abstract] [Full Text] [Related]
3. 2,2'-O-cyclocytidine, an antitumor cytidine analog resistant to cytidine deaminase.
Hoshi A; Kanazawa F; Kuretani K; Saneyoshi M; Arai Y
Gan; 1971 Apr; 62(2):145-6. PubMed ID: 5114632
[No Abstract] [Full Text] [Related]
4. Studies of the enzymatic deamination of cytosine arabinoside. 3. Substrate requirements and inhibitors of the deaminase of human liver.
Camiener GW
Biochem Pharmacol; 1967 Sep; 16(9):1691-702. PubMed ID: 6061556
[No Abstract] [Full Text] [Related]
5. Distribution and excretion of cyclocytidine in monkeys, dogs, and rats.
Hirayama H; Sugihara T; Hamada F; Kanai T; Hikita J
Gan; 1974 Apr; 65(2):153-61. PubMed ID: 4209835
[No Abstract] [Full Text] [Related]
6. Novel arabinofuranosyl derivatives of cytosine resistant to enzymatic deamination and possessing potent antitumor activity.
Bobek M; Cheng YC; Bloch A
J Med Chem; 1978 Jul; 21(7):597-8. PubMed ID: 276611
[No Abstract] [Full Text] [Related]
7. Studies of the enzymatic deamination of cytosine arabinoside. II. Properties of the deaminase of human liver.
Camiener GW
Biochem Pharmacol; 1967 Sep; 16(9):1681-9. PubMed ID: 4964068
[No Abstract] [Full Text] [Related]
8. Inhibition of Deamination of Arabinosylcytosine (NSC-63878) by Rhodium(II) Acetate.
Lee SH; Chao DL; Bear JL; Kimball AP
Cancer Chemother Rep; 1975; 59(3):661-3. PubMed ID: 1203890
[TBL] [Abstract][Full Text] [Related]
9. Distribution of kinase and deaminase of 1-beta-D-arabinofuranosylcytosine in tissues of man and mouse.
Ho DH
Cancer Res; 1973 Nov; 33(11):2816-20. PubMed ID: 4518302
[No Abstract] [Full Text] [Related]
10. Pharmacological disposition in mice of O 2 :2'-anhydro-1- -D-arabinosylcytosine 3'-phosphate, a potential antileukemic agent.
Focke JH; Broussard WJ; Nagyvary J
Biochem Pharmacol; 1973 Mar; 22(6):703-13. PubMed ID: 4693492
[No Abstract] [Full Text] [Related]
11. Metabolic fate of O2,2'-cyclocytidine.
Ho DH
Drug Metab Dispos; 1973; 1(6):752-5. PubMed ID: 4156296
[No Abstract] [Full Text] [Related]
12. Comparative reactivity of cytidine and arabinosylcytosine to their 6-methyl derivatives in the presence of cytidine deaminase.
DeYoung JL; Notari RE; Feller DR
Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):163-72. PubMed ID: 4474681
[No Abstract] [Full Text] [Related]
13. Effect of phosphorylated cyclocytidine on deoxyribonucleic acid polymerase.
Hoshi A; Kanzawa F; Kuretani K; Kanai T; Ichino M
Biochem Pharmacol; 1973 Nov; 22(22):2829-34. PubMed ID: 4761553
[No Abstract] [Full Text] [Related]
14. The purification and properties of cytidine deaminase from Escherichia coli.
Hosono H; Kuno S
J Biochem; 1973 Oct; 74(4):797-803. PubMed ID: 4202859
[No Abstract] [Full Text] [Related]
15. Arabinofuranosylcytosine-induced stimulation of thymidine kinase and deoxycytidylic deaminase activities of mammalian cultures.
Kit S; De Torres RA; Dubbs DR
Cancer Res; 1966 Sep; 26(9):1859-66. PubMed ID: 4958937
[No Abstract] [Full Text] [Related]
16. Purification and properties of cytidine deaminase from normal and leukemic granulocytes.
Chabner BA; Johns DG; Coleman CN; Drake JC; Evans WH
J Clin Invest; 1974 Mar; 53(3):922-31. PubMed ID: 4521417
[TBL] [Abstract][Full Text] [Related]
17. Studies in vitro on some precursors of 1- -D-arabinosylcytosine.
Hayashikawa RH; Nagyvary J
Biochem Pharmacol; 1973 Mar; 22(5):609-22. PubMed ID: 4692170
[No Abstract] [Full Text] [Related]
18. Distribution and excretion of 3H-cyclocytidine in rhesus monkeys.
Nishimura M; Hamada F; Sugihara T; Wakigawa K; Hirayama H
Nihon Juigaku Zasshi; 1975 Jun; 37(3):293-300. PubMed ID: 1238853
[No Abstract] [Full Text] [Related]
19. Correlation of mouse tissue distribution of arabinosylcytosine in vivo with enzymatic activities in vitro.
Ho DH
Drug Metab Dispos; 1976; 4(3):296-300. PubMed ID: 6236
[TBL] [Abstract][Full Text] [Related]
20. Recombinant gene products of two natural variants of the human cytidine deaminase gene confer different deamination rates of cytarabine in vitro.
Kirch HC; Schröder J; Hoppe H; Esche H; Seeber S; Schütte J
Exp Hematol; 1998 May; 26(5):421-5. PubMed ID: 9590659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
